In addition to regulating energy metabolism, EGCG can inhibit the mechanistic target of rapamycin (mTOR) signal and the activities of lipogenic enzymes of hepatoma cells by activating AMPK pathway, subsequently obstructing the protein and lipid synthesis in HCC (Huang et al., 2009). The gene discussed is MTOR; the disease is hepatocellular carcinoma.